3P Innovation has won a Princess Royal Training Award for its Graduate Development Programme (GDP).
Medtech and pharma automation provider, 3P Innovation, has won a Princess Royal Training Award for its Graduate Development Programme (GDP), the company announced in an Aug. 17, 2021 press release.
The GDP has been designed to follow the lifecycle of a 3P engineer, lasting two years, and is tailored to each participant by being competence-based and evolving to both the business’ needs and graduates’ expectations. Participants in the scheme, with support from senior management acting as mentors, will manage the process.
“The GDP addresses skills issues, which hampered growth. This initiative has been pivotal to our recent growth, and we have seen a wide range of benefits,” said David Seaward, founder and director of Projects at 3P Innovation, in the press release. “We have tangibly reduced staff turnover and recruitment costs. Staff satisfaction and improved morale are also very apparent as evidenced in our recent satisfaction survey, along with the desire to carry on working at 3P into the future. We have also seen rapid promotion of our graduate engineers as a further impact of the scheme. This enabled the senior management team to focus on other areas to further grow the business organically.”
Source: 3P Innovation
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.